Menu Close
Close
Contact

Expert Care for Progressive CIDP Symptoms

Specialist care for diagnosed or suspected CIDP, including progressive weakness, numbness, tingling, balance problems, reduced reflexes, and walking difficulty.

Request an Appointment
Call Southland Neuromuscular

CIDP damages the protective myelin around peripheral nerves, causing progressive or recurring weakness and sensory changes.

Common symptoms may include:

  • Gradually worsening arm or leg weakness
  • Tingling or numbness in hands and feet
  • Difficulty walking or climbing stairs
  • Poor balance or coordination
  • Reduced or absent reflexes
  • Burning, aching, or nerve pain
  • Hand weakness or difficulty gripping objects

Persistent or returning weakness deserves a closer evaluation.

Dr. Samir P. Macwan is ABPN Board Certified in both Neurology and Neuromuscular Medicine. He has practiced Neuromuscular Medicine in the Greater Palm Springs area for 15 years and has been involved in CIDP care and research involving immune-mediated neuropathies.

Why this matters for CIDP patients:

  • CIDP affects peripheral nerves and their protective myelin covering
  • Symptoms may resemble other neuropathies or muscle conditions
  • Diagnosis requires clinical judgment and targeted nerve testing
  • Treatment depends on progression, test results, and prior response

CIDP evaluation may include a neurologic examination, reflex and strength testing, EMG/NCS, blood or urine tests, and sometimes a lumbar puncture or imaging. Treatment may include IVIG, corticosteroids, plasma exchange, other immune therapies, rehabilitation, or clinical trial evaluation when appropriate.

Treatment decisions may depend on:

  • Speed and pattern of symptom progression
  • Muscle strength and walking ability
  • Sensory loss and reflex changes
  • EMG/NCS findings
  • Previous treatment response
  • Medical history and treatment tolerance
Start With an Evaluation

Advanced CIDP Care Backed by Research Experience

Southland Neuromuscular is involved in research-connected care for complex peripheral nerve disorders. Dr. Macwan has served as Principal Investigator for ongoing and completed CIDP studies involving immunoglobulin therapies and investigational immune treatments.

For eligible patients, care discussions may include IVIG, corticosteroids, plasma exchange, other immune therapies, rehabilitation, or clinical trial evaluation based on diagnosis, disease activity, treatment response, and clinical fit.

Explore Clinical Research

Know When CIDP Symptoms Need Urgent Care

Sudden or rapidly worsening weakness is not typical of stable CIDP and may require immediate medical evaluation.

Dr. Samir P. Macwan, neuromuscular specialist treating patients with myasthenia gravis
Dr. Samir P. Macwan

MD

Seek urgent help for:

  • Trouble breathing
  • Severe swallowing difficulty
  • Rapidly worsening weakness
  • Inability to stand or walk
  • Repeated falls or sudden loss of balance
  • Major speech or facial changes
  • Sudden loss of arm or leg function

Call 911 for Severe Symptoms

Call 911 for breathing, swallowing, walking, or rapidly worsening weakness.

CIDP FAQs

Early signs of CIDP may include gradually increasing weakness, tingling, numbness, poor balance, reduced reflexes, or difficulty walking and climbing stairs. Symptoms often affect both sides of the body and may progress continuously or improve before returning. Symptoms lasting eight weeks or longer may raise concern for CIDP.

CIDP and Guillain-Barré Syndrome both involve immune-related damage to peripheral nerves. GBS usually progresses rapidly over days or weeks, while CIDP generally develops, continues, or relapses over eight weeks or longer. Because early symptoms can overlap, the timeline, examination findings, and nerve conduction results help guide diagnosis.

CIDP is diagnosed through symptom history, neurological examination, strength and reflex testing, and EMG/NCS evidence of nerve demyelination. Blood and urine tests may help exclude other causes. In some cases, evaluation may also include a lumbar puncture, imaging of nerve roots, or other supportive testing.

CIDP treatment may include IVIG, corticosteroids, or plasma exchange. Some patients may require other immune therapies, rehabilitation, mobility support, or ongoing treatment to control relapses. The appropriate plan depends on symptom severity, nerve testing, medical history, treatment response, side effects, and whether the condition is progressive or relapsing.

Yes. CIDP may follow a progressive, relapsing-remitting, or occasionally single-episode course. Some patients improve and remain stable, while others experience returning weakness, numbness, balance problems, or reduced function. Ongoing monitoring helps determine whether treatment should continue, change, or restart when symptoms or examination findings worsen.

Many people with CIDP improve with appropriate treatment, although response and recovery vary. Treatment aims to limit further myelin and nerve damage, improve strength and function, reduce symptoms, and prevent relapse. Some patients require long-term therapy, while others may achieve sustained improvement or remission after treatment.

Get Specialized Care for CIDP

Request an Appointment